These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 11855679)

  • 61. Intrapulmonary pharmacodynamics of high-dose levofloxacin in subjects with chronic bronchitis or chronic obstructive pulmonary disease.
    Conte JE; Golden JA; McIver M; Little E; Zurlinden E
    Int J Antimicrob Agents; 2007 Nov; 30(5):422-7. PubMed ID: 17716873
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Carrier-mediated mechanism for the biliary excretion of the quinolone antibiotic grepafloxacin and its glucuronide in rats.
    Sasabe H; Tsuji A; Sugiyama Y
    J Pharmacol Exp Ther; 1998 Mar; 284(3):1033-9. PubMed ID: 9495864
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Penetration of levofloxacin into skin tissue after oral administration of multiple 750 mg once-daily doses.
    Chow AT; Chen A; Lattime H; Morgan N; Wong F; Fowler C; Williams RR
    J Clin Pharm Ther; 2002 Apr; 27(2):143-50. PubMed ID: 11975700
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Levofloxacin PK/PD: from sequential therapy model to high dosage for critical patients.
    Pea F; Furlanut M
    J Chemother; 2004 Apr; 16 Suppl 2():8-10. PubMed ID: 15255555
    [No Abstract]   [Full Text] [Related]  

  • 65. Grepafloxacin pharmacokinetics in individuals with hepatic dysfunction.
    Efthymiopoulos C; Bramer SL; Maroli A; Flaherty JF; Wolfe E; Bass N; Somberg K
    Clin Pharmacokinet; 1997; 33 Suppl 1():25-31. PubMed ID: 9433653
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Effect of levofloxacin on glycosaminoglycan and DNA synthesis of cultured rabbit chondrocytes at concentrations inducing cartilage lesions in vivo.
    Kato M; Takada S; Ogawara S; Takayama S
    Antimicrob Agents Chemother; 1995 Sep; 39(9):1979-83. PubMed ID: 8540702
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Antibacterial effects of moxifloxacin and levofloxacin simulating epithelial lining fluid concentrations against community-acquired methicillin-resistant Staphylococcus aureus.
    Lee SY; Fan HW; Sutherland C; DeRyke AC; Nicolau DP
    Drugs R D; 2007; 8(2):69-77. PubMed ID: 17324004
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Biopharmaceutical characterization of nebulized antimicrobial agents in rats: 1. Ciprofloxacin, moxifloxacin, and grepafloxacin.
    Gontijo AV; Brillault J; Grégoire N; Lamarche I; Gobin P; Couet W; Marchand S
    Antimicrob Agents Chemother; 2014 Jul; 58(7):3942-9. PubMed ID: 24798283
    [TBL] [Abstract][Full Text] [Related]  

  • 69. The effect of the corneal epithelium on the intraocular penetration of fluoroquinolone ophthalmic solution.
    Fukuda M; Inoue A; Sasaki K; Takahashi N
    Jpn J Ophthalmol; 2004; 48(2):93-6. PubMed ID: 15060787
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Absence of a pharmacokinetic interaction between intravenous theophylline and orally administered levofloxacin.
    Gisclon LG; Curtin CR; Fowler CL; Williams RR; Hafkin B; Natarajan J
    J Clin Pharmacol; 1997 Aug; 37(8):744-50. PubMed ID: 9378847
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Intrapulmonary pharmacokinetics and pharmacodynamics of high-dose levofloxacin in healthy volunteer subjects.
    Conte JE; Golden JA; McIver M; Zurlinden E
    Int J Antimicrob Agents; 2006 Aug; 28(2):114-21. PubMed ID: 16837169
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Effect of food and gastric pH on the bioavailability of grepafloxacin.
    Efthymiopoulos C; Bramer SL; Maroli A
    Clin Pharmacokinet; 1997; 33 Suppl 1():18-24. PubMed ID: 9433652
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Comparative evaluation of oral levofloxacin and parenteral nafcillin in the treatment of experimental methicillin-susceptible Staphylococcus aureus osteomyelitis in rabbits.
    Shirtliff ME; Calhoun JH; Mader JT
    J Antimicrob Chemother; 2001 Aug; 48(2):253-8. PubMed ID: 11481297
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Effect of age and gender on the pharmacokinetics of grepafloxacin.
    Efthymiopoulos C; Bramer SL; Maroli A
    Clin Pharmacokinet; 1997; 33 Suppl 1():9-17. PubMed ID: 9433651
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Levofloxacin penetration into epithelial lining fluid as determined by population pharmacokinetic modeling and monte carlo simulation.
    Drusano GL; Preston SL; Gotfried MH; Danziger LH; Rodvold KA
    Antimicrob Agents Chemother; 2002 Feb; 46(2):586-9. PubMed ID: 11796385
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Premarketing population pharmacokinetic study of levofloxacin in normal subjects and patients with infectious diseases.
    Tanigawara Y; Nomura H; Kagimoto N; Okumura K; Hori R
    Biol Pharm Bull; 1995 Feb; 18(2):315-20. PubMed ID: 7742805
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Concentrations of OPC-17116, a new fluoroquinolone antibacterial, in serum and lung compartments.
    Cook PJ; Andrews JM; Wise R; Honeybourne D; Moudgil H
    J Antimicrob Chemother; 1995 Feb; 35(2):317-26. PubMed ID: 7759395
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Grepafloxacin concentration in ocular tissues after intravenous infusion in rabbits with intraocular inflammation.
    Pérez-Oliván S; Pinilla I; Bregante MA; Solans C; Ruiz Moreno O; Garcia MA; Honrubia FM
    Ophthalmic Res; 2005; 37(6):335-40. PubMed ID: 16158011
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Pharmacokinetics of ciprofloxacin XR (1000 mg) versus levofloxacin (500 mg) in plasma and urine of male and female healthy volunteers receiving a single oral dose.
    Wagenlehner FM; Kinzig-Schippers M; Tischmeyer U; Wagenlehner C; Sörgel F; Dalhoff A; Naber KG
    Int J Antimicrob Agents; 2006 Jan; 27(1):7-14. PubMed ID: 16343856
    [TBL] [Abstract][Full Text] [Related]  

  • 80. [Effects of intravitreal levofloxacin on the rabbit retina].
    Ohkubo S; Mochizuki K; Torisaki M; Yamashita Y; Komatsu M; Tanahashi T; Ogata M; Kajimura T
    Nippon Ganka Gakkai Zasshi; 1996 Aug; 100(8):592-8. PubMed ID: 8810234
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.